Cargando…

Simplified (89)Zr-Labeling Protocol of Oxine (8-Hydroxyquinoline) Enabling Prolonged Tracking of Liposome-Based Nanomedicines and Cells

In this work, a method for the preparation of the highly lipophilic labeling synthon [(89)Zr]Zr(oxinate)(4) was optimized for the radiolabeling of liposomes and human induced pluripotent stem cells (hiPSCs). The aim was to establish a robust and reliable labeling protocol for enabling up to one week...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polyak, Andras, Bankstahl, Jens P., Besecke, Karen F. W., Hozsa, Constantin, Triebert, Wiebke, Pannem, Rajeswara Rao, Manstein, Felix, Borcholte, Thomas, Furch, Marcus, Zweigerdt, Robert, Gieseler, Robert K., Bengel, Frank M., Ross, Tobias L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309181/ https://www.ncbi.nlm.nih.gov/pubmed/34371788 http://dx.doi.org/10.3390/pharmaceutics13071097

Ejemplares similares

Comparative in vivo biodistribution of cells labelled with [(89)Zr]Zr-(oxinate)(4) or [(89)Zr]Zr-DFO-NCS using PET
por: Friberger, Ida, et al.
Publicado: (2023)

Process control and in silico modeling strategies for enabling high density culture of human pluripotent stem cells in stirred tank bioreactors
por: Manstein, Felix, et al.
Publicado: (2021)

Manganese-52: applications in cell radiolabelling and liposomal nanomedicine PET imaging using oxine (8-hydroxyquinoline) as an ionophore
por: Gawne, Peter, et al.
Publicado: (2018)

A kit formulation for the preparation of [(89)Zr]Zr(oxinate)(4) for PET cell tracking: White blood cell labelling and comparison with [(111)In]In(oxinate)(3)
por: Man, Francis, et al.
Publicado: (2020)

PET Imaging of Small Extracellular Vesicles via [(89)Zr]Zr(oxinate)(4) Direct Radiolabeling
por: Khan, Azalea A., et al.
Publicado: (2022)

Optimisation of the Synthesis and Cell Labelling Conditions for [(89)Zr]Zr-oxine and [(89)Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications
por: Friberger, Ida, et al.
Publicado: (2021)

Biodistribution of Mesenchymal Stromal Cells Labeled with [(89)Zr]Zr-Oxine in Local Radiation Injuries in Laboratory Animals
por: Astrelina, Tatiana A., et al.
Publicado: (2023)

Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications
por: Friberger, Ida, et al.
Publicado: (2022)

[(89)Zr]Oxinate(4) for long-term in vivo cell tracking by positron emission tomography
por: Charoenphun, Putthiporn, et al.
Publicado: (2014)

PET Imaging of Liposomal Glucocorticoids using (89)Zr-oxine: Theranostic Applications in Inflammatory Arthritis
por: Gawne, Peter J., et al.
Publicado: (2020)

Radiolabelling of Polyclonally Expanded Human Regulatory T Cells (Treg) with (89)Zr-oxine for Medium-Term In Vivo Cell Tracking
por: Jacob, Jacinta, et al.
Publicado: (2023)

Lung delivery of MSCs expressing anti-cancer protein TRAIL visualised with (89)Zr-oxine PET-CT
por: Patrick, P. Stephen, et al.
Publicado: (2020)

Evidence of Accumulated Endothelial Progenitor Cells in the Lungs of Rats with Pulmonary Arterial Hypertension by (89)Zr-oxine PET Imaging
por: Liu, Yimin, et al.
Publicado: (2020)

Imaging of cell-based therapy using (89)Zr-oxine ex vivo cell labeling for positron emission tomography
por: Kurebayashi, Yutaka, et al.
Publicado: (2021)

Spray-dried lactose-leucine microparticles for pulmonary delivery of antimycobacterial nanopharmaceuticals
por: Thiyagarajan, Durairaj, et al.
Publicado: (2021)

Bone marrow cell homing to sites of acute tibial fracture: (89)Zr-oxine cell labeling with positron emission tomographic imaging in a mouse model
por: Asiedu, Kingsley O., et al.
Publicado: (2018)

Biodistribution of (89)Zr-oxine-labeled human bone marrow-derived mesenchymal stem cells by micro-PET/computed tomography imaging in Sprague–Dawley rats
por: Wang, Shuzhe, et al.
Publicado: (2022)

Spatio-temporal biodistribution of (89)Zr-oxine labeled huLym-1-A-BB3z-CAR T-cells by PET imaging in a preclinical tumor model
por: Sta Maria, Naomi S., et al.
Publicado: (2021)

Toward Optimized (89)Zr-Immuno-PET: Side-by-Side Comparison of [(89)Zr]Zr-DFO-, [(89)Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [(89)Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?
por: Damerow, Helen, et al.
Publicado: (2022)

(89)Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art (89)Zr Radiochemistry
por: Heskamp, Sandra, et al.
Publicado: (2017)

Guidelines for the labelling of leucocytes with (111)In-oxine
por: Roca, Manel, et al.
Publicado: (2010)

Potential and pitfalls of (89)Zr-immuno-PET to assess target status: (89)Zr-trastuzumab as an example
por: Huisman, Marc C., et al.
Publicado: (2021)

Erratum to: Guidelines for the labelling of leucocytes with (111)In-oxine
por: Roca, Manel, et al.
Publicado: (2010)

High density bioprocessing of human pluripotent stem cells by metabolic control and in silico modeling
por: Manstein, Felix, et al.
Publicado: (2021)

Current Perspectives on (89)Zr-PET Imaging
por: Yoon, Joon-Kee, et al.
Publicado: (2020)

(89)Zr-immuno-PET using the anti-LAG-3 tracer [(89)Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC
por: Miedema, Iris H.C., et al.
Publicado: (2023)

Evaluation of (89)Zr-pertuzumab in Breast Cancer Xenografts
por: Marquez, Bernadette V., et al.
Publicado: (2014)

Heptadentate chelates for (89)Zr-radiolabelling of monoclonal antibodies
por: Guillou, Amaury, et al.
Publicado: (2022)

Development and evaluation of (89)Zr-trastuzumab for clinical applications
por: Mohammadpour-Ghazi, Fatemeh, et al.
Publicado: (2023)

Characterization of Chimeric Antigen Receptor Modified T Cells Expressing scFv-IL-13Rα2 after Radiolabeling with 89Zirconium Oxine for PET Imaging
por: Leland, Pamela, et al.
Publicado: (2023)

Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with (89)Zirconium oxine for PET imaging
por: Leland, Pamela, et al.
Publicado: (2023)

(89)Zr-cetuximab PET imaging in patients with advanced colorectal cancer
por: Menke-van der Houven van Oordt, Catharina Willemien, et al.
Publicado: (2015)

Correction: Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with (89)Zirconium oxine for PET imaging
por: Leland, Pamela, et al.
Publicado: (2023)

Annotating MYC oncogene status with (89)Zr-transferrin imaging
por: Holland, Jason P., et al.
Publicado: (2012)

Microfluidic Preparation of (89)Zr-Radiolabelled Proteins by Flow Photochemistry
por: Earley, Daniel F., et al.
Publicado: (2021)

Preparation and Anti-Tumour Activity of Some Arylbismuth(III) Oxine Complexes
por: Smith, Katharine A., et al.
Publicado: (1998)

TrisOxine abiotic siderophores for technetium complexation: radiolabeling and biodistribution studies
por: Leenhardt, Julien, et al.
Publicado: (2023)

(89)Zr-Cobalamin PET Tracer: Synthesis, Cellular Uptake, and Use for Tumor Imaging
por: Kuda-Wedagedara, Akhila N. W., et al.
Publicado: (2017)

Formation and Entrapment of Tris(8-hydroxyquinoline)aluminum from 8-Hydroxyquinoline in Anodic Porous Alumina
por: Yamaguchi, Shohei, et al.
Publicado: (2016)

(89)Zr-Radiolabeled Trastuzumab Imaging in Orthotopic and Metastatic Breast Tumors
por: Chang, Albert J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jnhqtltcgdl9upugra3r6elsob